AKAGERA Medicines
HOME
Mission Statement
PEOPLE
SCIENCE
NEWS & PUBLICATIONS
CONTACT
Back
SCIENCE TEAM
BOARD OF DIRECTORS
AKAGERA MEDICINES, AFRICA
SCIENCE ADVISORY BOARD
BUSINESS ADVISORY BOARD
A Letter About Joe Ritchie & Paul Farmer
A Note on our Multi-Culture
The Interns
Back
Strategy, Partners, Product Pipeline, IP
Tuberculosis
MRSA
Vaccine Delivery System
Drug Development Process
Back
Presentations, Podcasts & ARTICLES
BIBLIOGRAPHY
A Brief History of TB
Recent Rwandan Developments
Rwandan Leadership Conference
Back
General Contact
INVESTOR COMMUNICATION
HOME
Mission Statement
PEOPLE
SCIENCE TEAM
BOARD OF DIRECTORS
AKAGERA MEDICINES, AFRICA
SCIENCE ADVISORY BOARD
BUSINESS ADVISORY BOARD
A Letter About Joe Ritchie & Paul Farmer
A Note on our Multi-Culture
The Interns
SCIENCE
Strategy, Partners, Product Pipeline, IP
Tuberculosis
MRSA
Vaccine Delivery System
Drug Development Process
NEWS & PUBLICATIONS
Presentations, Podcasts & ARTICLES
BIBLIOGRAPHY
A Brief History of TB
Recent Rwandan Developments
Rwandan Leadership Conference
CONTACT
General Contact
INVESTOR COMMUNICATION
AKAGERA Medicines
a Rwandan Biotech
“Rwandan Values are an Advantage.” Speech at the beginning of the Global Pandemic.
Akagera Medicines chairman of the board, Michael Fairbanks — speaking at the Rwanda leadership conference as the Global Pandemic began.
A Framework for Action: Global Context, Values, Strategies, Institutions, positive and negative Results, and feedback loops.
The Rwanda Leadership Conference at the Combat Center for the Rwanda Defense Force — just as the global pandemic began.